ABCL
Price
$2.60
Change
+$0.07 (+2.77%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
774.77M
13 days until earnings call
JSPR
Price
$4.88
Change
+$0.33 (+7.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
65.65M
Ad is loading...

ABCL vs JSPR

Header iconABCL vs JSPR Comparison
Open Charts ABCL vs JSPRBanner chart's image
AbCellera Biologics
Price$2.60
Change+$0.07 (+2.77%)
Volume$23.06K
Capitalization774.77M
Jasper Therapeutics
Price$4.88
Change+$0.33 (+7.24%)
Volume$1.26K
Capitalization65.65M
ABCL vs JSPR Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. JSPR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and JSPR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ABCL: $2.54 vs. JSPR: $4.55)
Brand notoriety: ABCL and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 101% vs. JSPR: 115%
Market capitalization -- ABCL: $750.93M vs. JSPR: $65.65M
ABCL [@Biotechnology] is valued at $750.93M. JSPR’s [@Biotechnology] market capitalization is $65.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • JSPR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ABCL and JSPR are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +6.28% price change this week, while JSPR (@Biotechnology) price change was +16.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

JSPR is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($775M) has a higher market cap than JSPR($65.6M). ABCL YTD gains are higher at: -13.311 vs. JSPR (-78.718). JSPR has higher annual earnings (EBITDA): -74.87M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. JSPR (71.6M). JSPR has less debt than ABCL: JSPR (1.81M) vs ABCL (65.4M). ABCL has higher revenues than JSPR: ABCL (28.8M) vs JSPR (0).
ABCLJSPRABCL / JSPR
Capitalization775M65.6M1,181%
EBITDA-204.15M-74.87M273%
Gain YTD-13.311-78.71817%
P/E RatioN/AN/A-
Revenue28.8M0-
Total Cash626M71.6M874%
Total Debt65.4M1.81M3,607%
TECHNICAL ANALYSIS
Technical Analysis
ABCLJSPR
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 17 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
S17.310.95
+5.81%
SentinelOne
FSLY5.500.14
+2.61%
Fastly
TMUS259.351.05
+0.41%
T-Mobile US
BHRB50.82-0.12
-0.24%
Burke & Herbert Financial Services Corp
ITRG1.67-0.12
-6.70%
Integra Resources Corp

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.79%
CRSP - ABCL
62%
Loosely correlated
-1.76%
NTLA - ABCL
59%
Loosely correlated
-2.65%
ABSI - ABCL
57%
Loosely correlated
-0.47%
BEAM - ABCL
57%
Loosely correlated
+3.87%
RXRX - ABCL
57%
Loosely correlated
-0.89%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+4.12%
AUPH - JSPR
44%
Loosely correlated
+2.41%
ATNF - JSPR
38%
Loosely correlated
-2.16%
AVXL - JSPR
38%
Loosely correlated
+0.87%
MNMD - JSPR
36%
Loosely correlated
+5.00%
ABCL - JSPR
35%
Loosely correlated
+0.79%
More